세계 미용 임플란트 시장 규모는 2024-2030년의 예측 기간 동안 연평균 7.82% 성장할 전망입니다. 시장은 유방암 유병률 증가, 미용 수술 및 재건 성형 수술 증가, 미용 임플란트 관련 제품 출시 증가, 매력적인 신체 외관에 대한 요구 증가 등 다양한 요인으로 인해 긍정적인 성장을 보이고 있습니다. 따라서 시장은 2024-2030년의 예측 기간 동안 상당한 CAGR로 성장할 것으로 추정됩니다.
미용 임플란트 시장 역학
미용 임플란트 시장의 주요 촉진요인 중 하나는 전 세계적으로 유방암 유병률이 증가하고 있다는 점입니다. 예를 들어, 세계보건기구(WHO)가 2023년에 발표한 자료에 따르면 2020년 전 세계적으로 230만 명의 여성이 유방암 진단을 받았다고 합니다. 같은 자료와 통계에 따르면 전 세계적으로 지난 5년간 780만 명의 여성이 유방암 진단을 받았습니다. 따라서 전 세계적으로 유방암 유병률이 증가함에 따라 유방 보형물에 대한 수요도 급증하여 예측 기간(2024-2030년) 동안 전체 미용 보형물 시장을 견인할 것으로 보입니다.
또 다른 주요 성장 요인 중 하나는 미용 수술 및 재건 수술 증가로 미용 임플란트 시장의 또 다른 주요 성장 요인입니다. 예를 들어, 2020년 Plastic Surgery Statistics Report에 따르면 미국에서는 1,560만 건의 미용 성형 수술 중 230만 건이 미용 수술이었고, 1,320만 건이 최소 침습 수술이었습니다. 위 자료에 따르면 2020년 재건 수술은 680만 건(2019년 대비 3% 증가)으로 나타났습니다. 또한 위 자료에 따르면 2020년 유방 확대 수술은 19만 3,073건으로 실리콘 보형물이 전체의 84%, 식염수 보형물이 16%를 차지했습니다. 따라서 미용 수술 및 재건 수술 증가는 미용 임플란트에 대한 수요를 증가시켜 전체 미용 임플란트 시장의 성장을 가속할 것입니다.
따라서, 2024-2030년의 예측 기간 동안 위의 요인들이 전반적으로 미용 임플란트 시장을 견인할 것입니다.
그러나 미용 임플란트 관련 감염과 미용 임플란트의 높은 비용은 세계 미용 임플란트 시장의 성장을 저해할 수 있습니다.
코로나19 팬데믹으로 인해 입원이 제한되었을 뿐만 아니라 코로나19에 감염된 환자에 비해 선택적 수술의 우선순위가 낮아지면서 미용 임플란트 시장에 악영향을 미쳤습니다. 봉쇄 조치, 인력 부족, 마스크 및 PPE 키트 부족은 수술을 원하는 환자의 입원에 큰 영향을 미쳤습니다. 그러나 대중 예방접종, 봉쇄 조치 완화, 선택적 수술 재개, 마스크, PPE 키트 및 직원 가용성, 이 모든 조치가 정상화됨에 따라 미용 임플란트 시장은 다시 탄력을 받고 2024-2030년의 예측 기간 동안 더 많은 성장을 보일 것으로 예상됩니다.
북미가 전체 미용 임플란트 시장을 독점할 것으로 예상됩니다.
모든 지역 중 북미가 2023년 세계 미용 임플란트 시장을 장악할 것으로 예상되며, 2024-2030년 예측 기간에도 마찬가지일 것으로 예상됩니다. 유방암 유병률 증가, 미용 임플란트 관련 제품 출시 증가 등의 요인이 북미 시장에서 미용 임플란트 수요를 증가시킬 것으로 예측됩니다.
American Cancer Society가 2023년에 발표한 최신 데이터에 따르면, 미국에서는 2022년 말까지 45세 이하 여성 8명 중 1명이 침윤성 유방암에 걸릴 것이며, 침윤성 유방암 환자 3명 중 2명은 55세 이상 여성으로 진단될 것으로 예상됩니다. 따라서 유방암 유병률이 증가함에 따라 유방 보형물에 대한 수요도 급증할 수 있으며, 이는 예측 기간(2024-2030년) 동안 전체 미용 보형물 시장을 견인할 수 있습니다.
또한, 미용 임플란트 관련 제품 출시 증가와 같은 다른 요인들도 이 지역의 미용 임플란트 시장 전체를 견인할 수 있습니다. 예를 들어, 2022년 2월 세계 최대 미용 의료 전문 기업인 Merz Aesthetics는 미국에서 21세 이상 성인의 중등도에서 중증의 턱선 윤곽 손실을 개선하기 위해 연조직 강화(피하 및/또는 골막 상부)를 위한 심부 주입에 사용되는 Radiesse®(+) 리도카인(Lidocaine) 주입형 임플란트의 상업적 출시를 발표했습니다.
따라서, 앞서 언급한 요인의 상호작용은 미용 임플란트 시장에서 북미의 성장에 유리한 환경을 조성할 수 있습니다.
이 보고서는 세계 미용 임플란트 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 제공합니다.
Aesthetic Implants Market By Product Type (Breast Implants, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, And Others), By Gender (Male And Female), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of breast cancer and increase in number of cosmetic & reconstructive plastic surgeries
The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030. The aesthetic implants market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance. Therefore, the market for aesthetic implants is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.
Aesthetic Implants Market Dynamics:
One of the main drivers of the aesthetic implant market is the increasing prevalence of breast cancer globally. For instance, as per the World Health Organization (WHO) published data in the year 2023, in 2020, 2.3 million women were diagnosed with breast cancer throughout the world. According to the same source and statistics, across the world, 7.8 million women would have been diagnosed with breast cancer in the previous five years. Therefore, with the increasing global prevalence of breast cancer, the need for breast implants could also surge, driving the overall aesthetic implants market forward over the forecast period (2024-2030).
Moreover, another key factor that is responsible for the growth of the aesthetic implants market is the increase in the number of cosmetic & reconstructive surgeries. For instance, as per the plastic surgery statistics report in the year 2020, in America, out of 15.6 million cosmetic procedures, 2.3 million were cosmetic surgical procedures whereas 13.2 million procedures were minimally-invasive. According to the source mentioned above, in 2020, reconstructive procedures were 6.8 Million (a 3% increase from 2019). Additionally, as per the above-referenced source, in 2020, there were 193,073 breast augmentations, silicone implants accounting for 84% of all procedures, and saline implants accounting for 16%. Thus, an increase in the number of cosmetic & reconstructive surgeries will increase the demand for aesthetic implants, thereby propelling the growth of aesthetic implants' overall market.
Therefore, the factors stated above collectively will drive the aesthetic implants market during the forecast period from 2024-2030.
However, infections associated with the aesthetic implants and the high cost of aesthetic implants can hamper the global aesthetic implant market growth
The Coronavirus pandemic (COVID-19) has negatively impacted the market for aesthetic implants as hospital admissions were limited, as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks and PPE kits made a huge impact on patient admissions in hospitals for surgeries. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, with all these measures back on track the aesthetic implants market has picked momentum again and is expected to further grow during the forecast period from 2024-2030.
Aesthetic Implants Market Segment Analysis:
Aesthetic Implants Market by Product Type (Breast Implant, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, and Others), Gender (Male and Female), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In by product type segment of the dental implants market, is expected to share a significant revenue share in the year 2023. Benefits associated with dental implants are, as they are used to prevent bone loss, they act like natural teeth, the implants last a lifetime, they can be required to keep adjacent teeth stable, improve the appearance, oral health, self-esteem as well as speech, they are durable, help to get free from gum disease, help to prevent facial sagging & premature aging. Thus, these benefits associated with dental implants can increase the demand for aesthetic implants, which could drive the aesthetic implants' overall market growth.
However, various technologically advanced aesthetic implants receive approvals, this can also be expected to drive the overall market growth for aesthetic implants. For instance, in June 2022, Biotech Dental SAS, a designer and manufacturer of medical devices and digital solutions for dental surgeons, orthodontists, and dental prosthesis laboratories, received United States (US) Food and Drug Administration (FDA) approval for Kontact Dental Implant System, the implant system is designed to support single-unit, multiple-unit, or overdenture dental restorations in partly or completely edentulous patients.
Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for aesthetic implants, which in turn would provide a conducive growth environment for the overall aesthetic implants market during the forecast period from 2024-2030.
North America is expected to dominate the overall Aesthetic Implants Market:
Among all the regions, North America is expected to dominate the global aesthetic implants market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants are expected to increase the demand of aesthetic implants in the North America market.
According to the latest data published by the American Cancer Society in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older. Thus, with the increasing prevalence of breast cancer, the need for breast implants could also surge, this can drive the overall aesthetic implants market forward over the forecast period (2024-2030).
Furthermore, another factor such as the rise in the product launches related to aesthetic implants could drive the aesthetic implant's overall market in the region. For instance, in February 2022, Merz Aesthetics, the world's largest dedicated medical aesthetics company, announced the commercial launch of Radiesse® (+) Lidocaine injectable implant, for deep injection (subdermal and/or supraperiosteal) in the United States for soft tissue augmentation to improve moderate to a severe loss of jawline contour in adults over the age of 21.
Therefore, the interplay of the aforementioned factors would provide a conducive growth environment for the North American region in the aesthetic implants market.
Aesthetic Implants Market Key Players:
Some of the key market players operating in the aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.
Recent Developmental Activities in the Aesthetic Implants:
In May 2022, GC Aesthetics®, Inc. (GCA), a privately-held medical technology company providing healthcare aesthetic solutions, announced the launch of an Innovative Nipple Areola Complex (NAC) Reconstruction Implant: FixNip(TM) NRI
In May 2022, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced the launch of its next generation of breast implants, PERLE(TM). It's a cutting-edge series of smooth breast implants with a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (EmunomicTM Breast Tissue Dynamic Gel), and an upgraded version of GCA's long-term great safety record
In November 2019, BellaSeno, a German additive manufacturing start-up & Evonik, a chemical company, BellaSeno, and Evonik have formed a long-term partnership to develop a new breast implant technology based on Evonik's RESOMER bioresorbable polymer. RESOMER will be used in BellaSeno's 3D-printed senella breast scaffold. The product is designed to be used after reconstruction, augmentation, or revision surgery. It is resorbed by the body and gradually replaced by natural breast tissue
Key Takeaways from the Aesthetic Implants Market Report Study:
Target Audience who can be benefited from this Aesthetic Implants Market Report Study:
Frequently Asked Questions for Aesthetic Implants:
Aesthetic implant placement is driven by both a restorative and biological philosophy. The implant is positioned to meet the contour requirements for a good repair and should be positioned biologically to allow for the preservation of both hard and soft tissue architecture.
The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030.
The Aesthetic implants market is witnessing positive market growth owing to the factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance
Some of the key market players operating in the Aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.
North America is expected to dominate the global aesthetic implants market. Factors contributing to the growth are the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants, which are contributing to the growth of the aesthetic implants market in the North America region.